Your browser doesn't support javascript.
loading
Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial.
Pal, Sumanta K; Frankel, Paul H; Mortazavi, Amir; Milowsky, Matthew; Vaishampayan, Ulka; Parikh, Mamta; Lyou, Yung; Weng, Peng; Parikh, Rahul; Teply, Benjamin; Dreicer, Robert; Emamekhoo, Hamid; Michaelson, Dror; Hoimes, Christopher; Zhang, Tian; Srinivas, Sandy; Kim, William Y; Cui, Yujie; Newman, Edward; Lara, Primo N.
Afiliação
  • Pal SK; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Frankel PH; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Mortazavi A; Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus.
  • Milowsky M; Department of Medicine, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Vaishampayan U; Department of Internal Medicine, University of Michigan Cancer Center, Ann Arbor.
  • Parikh M; Department of Internal Medicine, UC Davis Comprehensive Cancer Center, Sacramento, California.
  • Lyou Y; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Weng P; Department of Internal Medicine, University of Kentucky Markey Cancer Center, Lexington.
  • Parikh R; Department of Internal Medicine, University of Kansas Medical Center, Westwood.
  • Teply B; Department of Internal Medicine, University of Nebraska Medical Center, Omaha.
  • Dreicer R; Department of Medicine, University of Virginia Cancer Center, Charlottesville.
  • Emamekhoo H; Department of Medicine, University of Wisconsin Cancer Center, Madison.
  • Michaelson D; Department of Medicine, Massachusetts General Hospital, Boston.
  • Hoimes C; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Zhang T; Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Srinivas S; Department of Medicine, Stanford Cancer Center, Palo Alto, California.
  • Kim WY; Department of Medicine, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina.
  • Cui Y; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Newman E; Department of Medical Oncology and Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, California.
  • Lara PN; Department of Internal Medicine, UC Davis Comprehensive Cancer Center, Sacramento, California.
JAMA Oncol ; 7(10): 1536-1543, 2021 Oct 01.
Article em En | MEDLINE | ID: mdl-34436521
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Bexiga Urinária / Carcinoma de Células de Transição Idioma: En Ano de publicação: 2021 Tipo de documento: Article